Skip to main content
Cencora10-Q: Debt refinancing

Cencora raised $4.5B in new debt and notes in early 2026 to fund the OneOncology acquisition.

What happened

In January and February 2026, the company secured $1.5B in term loans and issued $3.0B in senior notes to finance a major acquisition. This large-scale capital activity indicates significant M&A integration complexity and a potential need for financial management, reporting, and treasury solutions.

Source

SEC EDGARMay 6, 2026

Quarterly report (Form 10-Q)

Cencora 10-Q

Filing excerpt

In January 2026, we entered into an agreement pursuant to which we obtained a $1.5 billion delayed draw multi-year senior unsecured term loan facility.

sec.gov/Archives/edgar/data/1140859/000114085926000020/cor-20260331.htmRead the full source

Other signals in this filing (7)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Debt refinancing

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end
03/31
Filed
May 6, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$4.5B (Total new debt facilities and notes ($1.5B term loan + $3.0B notes) to finance the OneOncology acquisition.)

Details

CIK
1140859
Accession number
0001140859-26-000020
Timeframe
Current year
Filing year
2026
Fiscal year
0
Why it matters
Capital available or pressure
Signal category
Financial

Topics and mentions

Vendors

  • U.S. Bank Trust Company
  • National Association
  • JPMorgan Chase Bank
  • N.A.
  • Citibank
  • Citigroup Global Markets Inc.
  • J.P. Morgan Securities LLC
  • BofA Securities
  • Inc.
  • Wells Fargo Securities
  • LLC

Vendors named

  • U.S. Bank Trust Company, National Association
  • JPMorgan Chase Bank, N.A.
  • Citibank, N.A.
  • Citigroup Global Markets Inc.
  • J.P. Morgan Securities LLC
  • BofA Securities, Inc.
  • Wells Fargo Securities, LLC

Extraction

Confidence
High
Relevance
90%
Sentiment
Neutral
Detected
May 12, 2026
signal_type
sec-10q
signal_subtype
debtRefinancing

Use this data

Get every 10-Q signal for Cencora and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Cencora this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/c7dcb785-5467-433c-a109-5c3646e7a12a returns this record as JSON. POST /v1/companies/enrich returns every signal for cencora.com.

{
  "signal_id": "c7dcb785-5467-433c-a109-5c3646e7a12a",
  "signal_type": "sec-10q",
  "signal_subtype": "debtRefinancing",
  "detected_at": "2026-05-12T09:24:56.054+00:00",
  "company": {
    "name": "Cencora",
    "domain": "cencora.com"
  },
  "data": {
    "detail": "In January and February 2026, the company secured $1.5B in term loans and issued $3.0B in senior notes to finance a major acquisition. This large-scale capital activity indicates significant M&A integration complexity and a potential need for financial management, reporting, and treasury solutions.",
    "metrics": {
      "timeframe": "current_year",
      "dollar_context": "Total new debt facilities and notes ($1.5B term loan + $3.0B notes) to finance the OneOncology acquisition.",
      "dollar_millions": 4500
    },
    "summary": "Cencora raised $4.5B in new debt and notes in early 2026 to fund the OneOncology acquisition.",
    "excerpts": "In January 2026, we entered into an agreement pursuant to which we obtained a $1.5 billion delayed draw multi-year senior unsecured term loan facility.",
    "relevance": 0.9,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1140859/000114085926000020/cor-20260331.htm",
    "filing_date": "2026-05-06",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "03/31",
    "sales_relevance": "Capital available or pressure",
    "signal_category": "financial",
    "vendors_mentioned": [
      "U.S. Bank Trust Company, National Association",
      "JPMorgan Chase Bank, N.A.",
      "Citibank, N.A.",
      "Citigroup Global Markets Inc.",
      "J.P. Morgan Securities LLC",
      "BofA Securities, Inc.",
      "Wells Fargo Securities, LLC"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.